Genetics of Hyperaldosteronism and a Wealth of New Information on Topics Ranging from MEN1 to Cushing's Disease and Metabolic Syndrome

Overview

Journal Hormones (Athens)

Specialty Endocrinology

Date 2022 Nov 15

PMID 36380266

Authors

Constantine A Stratakis

Affiliations

Soon will be listed here.

References

Pitsava G, Faucz F, Stratakis C, Hannah-Shmouni F . Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas. Curr Cardiol Rep. 2022; 24(9):1189-1195. PMC: 9667367. DOI: 10.1007/s11886-022-01735-z. View

Asbach E, Kellnar A, Bekeran M, Schelling J, Bidlingmaier M, Reincke M . Prevalence of Primary Aldosteronism in Newly Diagnosed Hypertensive Patients in Primary Care. Exp Clin Endocrinol Diabetes. 2022; 130(12):801-805. DOI: 10.1055/a-1938-4242. View

Spyroglou A, Handgriff L, Muller L, Schwarzlmuller P, Parasiliti-Caprino M, Fuss C . The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. Eur J Endocrinol. 2022; 187(3):361-372. DOI: 10.1530/EJE-22-0040. View

Le Floch E, Cosentino T, Larsen C, Beuschlein F, Reincke M, Amar L . Identification of risk loci for primary aldosteronism in genome-wide association studies. Nat Commun. 2022; 13(1):5198. PMC: 9440917. DOI: 10.1038/s41467-022-32896-8. View

Joseph J, Zhou X, Zilbermint M, Stratakis C, Faucz F, Lodish M . The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure, and Glycemia in African Americans. J Clin Endocrinol Metab. 2020; 105(8). PMC: 7308077. DOI: 10.1210/clinem/dgaa290. View

Mourtzi N, Sertedaki A, Markou A, Piaditis G, Katsanis N, Traeger-Synodinos J . Genetic screening of hypertensive patients with aldosterone hypersecretion under conditions of stress. Hormones (Athens). 2022; 21(4):525-536. DOI: 10.1007/s42000-022-00394-7. View

Araujo-Vilar D, Fernandez-Pombo A, Cobelo-Gomez S, Castro A, Sanchez-Iglesias S . Lipodystrophy-associated progeroid syndromes. Hormones (Athens). 2022; 21(4):555-571. DOI: 10.1007/s42000-022-00386-7. View

Pal S, Eslam M, Mendez-Sanchez N . Correction to: Detangling the interrelations between MAFLD, insulin resistance, and key hormones. Hormones (Athens). 2022; 21(4):759. DOI: 10.1007/s42000-022-00395-6. View

11.

Bletsa E, Paschou S, Tsigkou V, Stampouloglou P, Vasileiou V, Kassi G . The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review. Hormones (Athens). 2022; 21(4):599-610. DOI: 10.1007/s42000-022-00403-9. View

12.

Salimi M, Eskandari F, Khodagholi F, Abdollahifar M, Hedayati M, Zardooz H . Correction: Perinatal stress exposure induced oxidative stress, metabolism disorder, and reduced GLUT-2 in adult offspring of rats. Hormones (Athens). 2022; 21(4):751-757. DOI: 10.1007/s42000-022-00393-8. View

13.

Xu R, Feng J, Liang C, Song G, Yan Y . Effects of high-fat diet and treadmill running on the hypothalamic Kiss-1-GPR54 signaling pathway in male growing rats. Hormones (Athens). 2022; 21(4):641-652. PMC: 9712360. DOI: 10.1007/s42000-022-00389-4. View

14.

Taouktsi N, Papageorgiou S, Tousinas G, Papanikolopoulou S, Grammatikopoulou M, Giannakoulas G . Fragility of cardiovascular outcome trials (CVOTs) examining nutrition interventions among patients with diabetes mellitus: a systematic review of randomized controlled trials. Hormones (Athens). 2022; 21(4):665-681. PMC: 9712353. DOI: 10.1007/s42000-022-00396-5. View

15.

Zhang Z, Chen Y, Wang Q, Xie L, Shan Y, Yang N . Influence of fasting plasma glucose-lowering rate on BNP levels in type 2 diabetes mellitus patients with coronary microcirculation dysfunction. Hormones (Athens). 2022; 22(1):33-43. DOI: 10.1007/s42000-022-00404-8. View

16.

Abbasian S, Ravasi A, Soori R, Aydin S, Choobineh S, Aydin S . High-intensity interval training ameliorates endothelial dysfunction through adropin, nitric oxide, MR-proADM, and copeptin changes in overweight subjects. Hormones (Athens). 2022; 21(4):707-717. DOI: 10.1007/s42000-022-00402-w. View

17.

Sendur S, Firlatan B, Baykal G, Lay I, Erbas T . Serum growth differentiation factor-15 levels are associated with the severity of diabetic foot ulcer. Hormones (Athens). 2022; 21(4):719-728. DOI: 10.1007/s42000-022-00408-4. View

18.

Mao Y, Goulden P, Fan C, Maraka S . A novel MEN1 gene mutation associated with a pancreatic neuroendocrine tumor co-producing insulin and vasoactive intestinal polypeptide. Hormones (Athens). 2022; 21(4):743-745. DOI: 10.1007/s42000-022-00356-z. View

19.

Dzialach L, Sobolewska J, Respondek W, Wojciechowska-Luzniak A, Witek P . Cushing's syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia. Hormones (Athens). 2022; 21(4):735-742. PMC: 9712315. DOI: 10.1007/s42000-022-00397-4. View

20.

Pang Q, Jia A, Al Masri M, Kord Varkaneh H, Abu-Zaid A, Gao X . The effect of androstenedione supplementation on testosterone, estradiol, body composition, and lipid profile: a systematic review and meta-analysis of randomized controlled trials. Hormones (Athens). 2022; 21(4):545-554. DOI: 10.1007/s42000-022-00385-8. View

21.

Stramazzo I, Capriello S, Antonelli A, Fallahi P, Centanni M, Virili C . Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer. Hormones (Athens). 2022; 21(4):537-543. PMC: 9712340. DOI: 10.1007/s42000-022-00376-9. View

22.

Schoning J, Flitsch J, Ludecke D, Fahlbusch R, Buchfelder M, Buslei R . Multiple tumorous lesions of the pituitary gland. Hormones (Athens). 2022; 21(4):653-663. PMC: 9712358. DOI: 10.1007/s42000-022-00392-9. View